Neurobiology of delusions in Alzheimer's disease

Current Psychiatry Reports

Volumn 13, Issue 3, 2011, Pages 211-218

  Ismail, Zahinoor ^a,d   Nguyen, Minh Quan ^a   Fischer, Corinne E ^a,b   Schweizer, Tom A ^c   Mulsant, Benoit H ^a   Mamo, David ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Alzheimer's; BPSD; Cognition; Confabulation; Delusions; Dementia; Genetics; Misidentifications; Neuropathology; Neuropsychiatric symptoms; Neuropsychiatry; NPS; Paranoia; Persecutory delusions; Psychosis; Suspiciousness

Indexed keywords

ALZHEIMER DISEASE; APOLIPOPROTEIN E4 GENE; ARTICLE; COGNITIVE DEFECT; DELUSION; DELUSIONAL MISIDENTIFICATION; DEMENTIA; DOPAMINE RECEPTOR 3 GENE; FRONTAL LOBE; FUNCTIONAL DISEASE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HALLUCINATION; HOMOZYGOSITY; HUMAN; INTERLEUKIN 1BETA GENE; MILD COGNITIVE IMPAIRMENT; NEUROBIOLOGY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PERSECUTORY DELUSION; PSYCHOSIS; RISK FACTOR; SENILE PLAQUE; SEROTONIN 2A RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; DELUSIONS; HUMANS;

EID: 79955910047     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-011-0195-1     Document Type: Article

References (50)

1. Steinberg M, Shao H, Zandi P, et al. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry. 2008;23:170-7. (Pubitemid 351308497)
2. Wiener PK, Kiosses DN, Klimstra S, et al. A short-term inpatient program for agitated demented nursing home residents. Int J Geriatr Psychiatry. 2001;16:866-72. (Pubitemid 32926770)
3. Alzheimer A. Uber eine eigenartige rkrankung der hirnrinde. Allg Z Psychiat Psych Gerichtl Med. 1907;64:146-8.
4. Fischer C, Bozanovic-Sosic R, Norris M. Review of delusions in dementia. Am J Alzheimer's Dis Other Dements. 2004;19:19-23.
5. Holt AE, Albert ML. Cognitive neuroscience of delusions in aging. Neuropsychiatr Dis Treat. 2006;2:181-9. (Pubitemid 44043611)
6. Jeste DV, Finkel SI. Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry. 2000;8:29-34. (Pubitemid 30036838)
7. Schneider LS, Katz IR, Park S, et al. Psychosis of Alzheimer disease: validity of the construct and response to risperidone. Am J Geriatr Psychiatry. 2003;11:414-25. (Pubitemid 36807637)
8. Lyketsos CG, Breitner JC, Rabins PV. An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease. Int J Geriatr Psychiatry. 2001;16:1037-42. (Pubitemid 33089267)
9. Mizrahi R, Starkstein SE, Jorge R, et al. Phenomenology and clinical correlates of delusions in Alzheimer disease. Am J Geriatr Psychiatry. 2006;14:573-81. (Pubitemid 44036481)
10. Cook SE, Miyahara S, Bacanu SA, et al. Psychotic symptoms in Alzheimer disease: evidence for subtypes. Am J Geriatr Psychiatry. 2003;11:406-13. (Pubitemid 36807636)
11. Perez-Madrinan G, Cook SE, Saxton JA, et al. Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype. Am J Geriatr Psychiatry. 2004;12:449-56. (Pubitemid 39181060)
12. Forstl H, Besthorn C, Burns A, et al. Delusional misidentification in Alzheimer's disease: a summary of clinical and biological aspects. Psychopathology. 1994;27:194-9. (Pubitemid 24314117)
13. Ropacki SA, Jeste DV. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry. 2005;162:2022-30.
14. Weamer EA, Emanuel JE, Varon D, et al. The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis. Int psychogeriatrics IPA. 2009;21:78-85.
15. Ostling S, Gustafson D, Blennow K, et al: Psychotic Symptoms in a Population- Based Sample of 85-Year-Old Individuals With Dementia. J Geriatr Psychiatry Neurol.
16. Gauthier S, Cummings J, Ballard C, et al. Management of behavioral problems in Alzheimer's disease. Int psychogeriatrics IPA. 2010;22:346-72.
17. Sweet RA, Bennett DA, Graff-Radford NR, et al. Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study. Brain. 2010;133:1155-62.
18. Harciarek M, Kertesz A. The prevalence of misidentification syndromes in neurodegenerative diseases. Alzheimer disease and associated disorders 2008; 22:163-169
19. Savva GM, Zaccai J, Matthews FE, et al. Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. Br J Psychiatry. 2009;194:212-9. This was a large longitudinal study that assessed the prevalence and incidence of NPS in dementia. Importantly, misidentifications were assessed separately from persecutory delusions and had differing incidence rates as well as differing associations in factor analysis.
20. Jeste DV, Wragg RE, Salmon DP, et al. Cognitive deficits of patients with Alzheimer's disease with and without delusions. Am J Psychiatry. 1992;149:184-9.
21. Hamilton L, Fay S, Rockwood K. Misplacing objects in mild to moderate Alzheimer's disease: a descriptive analysis fromthe VISTA clinical trial. J Neurol Neurosurg Psychiatry. 2009;80:960-5.
22. Murayama N, Iseki E, Endo T, et al. Risk factors for delusion of theft in patients with Alzheimer's disease showing mild dementia in Japan. Aging Ment Health. 2009;13:563-8.
23. Nagata T, Ishii K, Ito T, et al. Correlation between a reduction in Frontal Assessment Battery scores and delusional thoughts in patients with Alzheimer's disease. Psychiatry Clin Neurosci. 2009;63:449-54. This was a very important study of the role of cognition and delusions in AD. Methodologically, this study is important because it assessed persecutory delusions as separate from misidentifications and used the FAB rather than a crude global measure such as the MMSE.
24. Nedjam Z, Devouche E, Dalla Barba G. Confabulation, but not executive dysfunction discriminate AD from frontotemporal dementia. Eur J Neurol. 2004;11:728-33. (Pubitemid 39556752)
25. Fischer CE, Verhoeff NP, Churchill K, et al. Functional outcome in delusional Alzheimer disease patients. A systematic review. Dement Geriatr Cogn Disord. 2009;27:105-10.
26. Zubenko GS, Moossy J, Martinez AJ, et al. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol. 1991;48:619-24.
27. Forstl H, Burns A, Levy R, et al. Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease. Br J Psychiatry. 1994;165:53-9. (Pubitemid 24224836)
28. Mukaetova-Ladinska EB, Harrington CR, Roth M, et al. Biochemical, neuropathological, and clinical correlations of neurofibrillary degeneration in Alzheimer's disease. In: Bergener M, Finkel SI, editors. Treating Alzheimer's and other dementias. New York: Springer; 1995. p. 57-80.
29. Farber NB, Rubin EH, Newcomer JW, et al. Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. Arch Gen Psychiatry. 2000;57:1165-73.
30. Lai MK, Lai OF, Keene J, et al. Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex. Neurology. 2001;57:805-11. (Pubitemid 32845499)
31. Sweet RA, Panchalingam K, Pettegrew JW, et al. Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiol Aging. 2002;23:547-53. (Pubitemid 34493887)
32. Shinno H, Inagaki T, Miyaoka T, et al. A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease. J Neurol Sci. 2007;260:132-8. (Pubitemid 47212216)
33. Tunstall N, Owen MJ, Williams J, et al. Familial influence on variation in age of onset and behavioural phenotype in Alzheimer's disease. Br J Psychiatry. 2000;176:156-9. (Pubitemid 32734841)
34. Avramopoulos D, Fallin MD, Bassett SS. Linkage to chromosome 14q in Alzheimer's disease (AD) patients without psychotic symptoms. Am J Med Genet B Neuropsychiatr Genet. 2005;132:9-13. (Pubitemid 40066187)
35. DeMichele-Sweet MA, Sweet RA. Genetics of psychosis in Alzheimer's disease: a review. J Alzheimers Dis. 2010;19:761-80.
36. Weiner MF, Vega G, Risser RC, et al. Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry. 1999;45:633-8. (Pubitemid 29147373)
37. Scarmeas N, Brandt J, Albert M, et al. Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology. 2002;58:1182-8. (Pubitemid 34411861)
38. Chang JB, Wang PN, Chen WT, et al. ApoE epsilon4 allele is associated with incidental hallucinations and delusions in patients with AD. Neurology. 2004;63:1105-7. (Pubitemid 39287928)
39. Spalletta G, Bernardini S, Bellincampi L, et al. Delusion symptoms are associated with ApoE epsilon4 allelic variant at the early stage of Alzheimer's disease with late onset. Eur J Neurol. 2006;13:176-82.
40. van der Flier WM, Staekenborg S, Pijnenburg YA, et al. Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dement Geriatr Cogn Disord. 2007;23:42-6. (Pubitemid 46005790)
41. Pritchard AL, Harris J, Pritchard CW, et al. The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2007;78:123-6. (Pubitemid 46220206)
42. Assal F, Alarcon M, Solomon EC, et al. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol. 2004;61:1249-53. (Pubitemid 39062679)
43. Angelucci F, Bernardini S, Gravina P, et al. Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism (102 T/C) in Alzheimer's disease: a 3-year follow-up longitudinal study. J Alzheimers Dis. 2009;17:203-11.
44. Lam LC, Tang NL, Ma SL, et al. 5-HT2A T102C receptor polymorphism and neuropsychiatric symptoms in Alzheimer's disease. Int J Geriatr Psychiatry. 2004;19:523-6. (Pubitemid 38877999)
45. Holmes C, Arranz MJ, Powell JF, et al. 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Hum Mol Genet. 1998;7:1507-9. (Pubitemid 28429933)
46. Borroni B, Grassi M, Agosti C, et al. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol Aging. 2006;27:1595-603. (Pubitemid 44363107)
47. Holmes C, Smith H, Ganderton R, et al. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation. J Neurol Neurosurg Psychiatry. 2001;71:777-9. (Pubitemid 33121920)
48. Craig D, Hart DJ, McCool K, et al. The interleukin 1beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia. Ann Neurol. 2004;56:121-4. (Pubitemid 38857367)
49. Carson R, Craig D, Hart D, et al. Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease. Neuromolecular Med. 2008;10:377-84. This was a newer genetic study showing an association of a novel gene in the study of delusions in dementia, but one that has been studied in schizophrenia, demonstrating a potential association between the two.
50. Pollock BG, Mulsant BH, Rosen J, et al. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry. 2007;15:942-52.